Express delivery and free returns within 21 days

Monday, June 27, 2022

MEDICAL DEVICE NEWS MAGAZINE

|

Contact us 561.316.3330

Jack Wang Ph.D. Appointed to Pressao Medical BOD: An Accomplished Business Leader

Jack Wang, Ph.D. has been appointed to the Board of Directors of Pressao Medical. Wang is an accomplished business leader with more than 20 years’ experience in the medical device industry (including Biosensors International, Johnson & Johnson and Guidant Corporation) with a successful track record in business execution and exits.

Currently, Jack is the chairman and CEO of HeMo Bioengineering Limited, a medical device company established in 2017, primarily focusing on neurovascular intervention in Asia, with its current manufacturing and marketing and sales headquarters in China. Previously, Jack was the CEO of Biosensors International, a pioneer in interventional cardiology devices, where he was responsible for the company’s significant growth and strategic direction leading to the acquisition of several successful companies.

A graduate of Case Western Reserve University, Jack has been granted more than 20 U.S. and European patents in medical devices and technology and has published more than 30 scientific papers on polymer materials and processing.

“We are excited to welcome Dr. Jack Wang to our board. His unique combination of vast industry experience and perspective will be critical as we prepare for international market entry,” says Shawn Moaddeb, the chairman of Pressao Medical.

Subscribe to Medical Device News Magazine

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.
Subscribe to Medical Device News Magazine

CAPS Medical Enrolls Patients from Sheba Medical Center in First Ever Study for Treatment of Bladder Cancer Using Selective Endoscopic Cancer Treatment Technology

CAPS Medical is conducting revolutionary endoscopic treatment of tumors using non-thermal plasma, suitable for a variety of cancer types.

Envoy Medical Reports FDA Approves Clinical Trial of First Fully Implanted Cochlear Implant

If approved by the FDA, the Acclaim would be the first-of-its-kind cochlear implant designed to be fully implanted and use the ear, rather than a microphone, to pick up sound notes Envoy Medical.

Radicle Science Reports History’s Largest Cannabinoid Trial on Pain Finds Significant Improvement

Radicle Science reports results demonstrated clinically meaningful improvements in pain across the different formulations of CBD and rare cannabinoids studied.

By using this website you agree to accept Medical Device News Magazine Privacy Policy